Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell–mediated angioedema
Angioedema (AE), transient localized swelling due to extravasated fluid, is commonly
classified as mast cell mediator-induced, bradykinin-mediated or of unknown cause. AE …
classified as mast cell mediator-induced, bradykinin-mediated or of unknown cause. AE …
[HTML][HTML] The international WAO/EAACI guideline for the management of hereditary angioedema–the 2021 revision and update
Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …
Epidemiology, management, and treatment access of hereditary angioedema in the Asia Pacific region: outcomes from an international survey
Background Hereditary angioedema (HAE) is a rare genetic disease with significant
morbidity and mortality for which early diagnosis and effective therapy are critical. Many Asia …
morbidity and mortality for which early diagnosis and effective therapy are critical. Many Asia …
Sensitivity to change and minimal clinically important difference of the angioedema control test
LM Fijen, C Vera, T Buttgereit… - Clinical and …, 2023 - Wiley Online Library
Abstract Background The Angioedema Control Test (AECT) is a patient‐reported outcome
measure developed and validated for the assessment of disease control in patients with …
measure developed and validated for the assessment of disease control in patients with …
Lanadelumab efficacy, safety, and injection interval extension in HAE: a real-life study
T Buttgereit, C Vera, K Weller, A Gutsche… - The Journal of Allergy …, 2021 - Elsevier
Background Lanadelumab has been available in Germany for the prophylactic treatment of
hereditary angioedema since February 2019. Objective To investigate real-life treatment …
hereditary angioedema since February 2019. Objective To investigate real-life treatment …
Prophylactic treatment in hereditary angioedema is associated with reduced anxiety in patients in Leipzig, Germany
J Zarnowski, M Rabe, P Kage, JC Simon… - International Archives of …, 2021 - karger.com
Background: Hereditary angioedema (HAE) is associated with relevant disease-related
burden. We aimed at investigating prevalence of depression and anxiety in patients with …
burden. We aimed at investigating prevalence of depression and anxiety in patients with …
Food immunotherapy practice: nation differences across Europe, the FIND project
P Rodríguez del Río, A Alvarez‐Perea, K Blumchen… - Allergy, 2022 - Wiley Online Library
Background Food allergen immunotherapy (FA‐AIT) practice is known to vary globally. This
project aims to identify and characterize European centres performing FA‐AIT. Methods An …
project aims to identify and characterize European centres performing FA‐AIT. Methods An …
[HTML][HTML] Patient-reported outcome measures for angioedema: a literature review
ATH Brix, HB Boysen, K Weller… - Acta Dermato …, 2021 - ncbi.nlm.nih.gov
Angioedema and hereditary angioedema are characterized by swelling of the subcutaneous
and/or submucosal tissue, resulting in localized oedema. The rarity, but also the diverse …
and/or submucosal tissue, resulting in localized oedema. The rarity, but also the diverse …
Berotralstat in hereditary angioedema due to C1 inhibitor deficiency: first real-world evidence from a Canadian center
Background Hereditary angioedema due to C1 inhibitor deficiency is a rare genetic
condition that causes recurrent swelling with consequent functional impairment and …
condition that causes recurrent swelling with consequent functional impairment and …